Physician-supervised injectable peptide therapy for advanced wellness protocols. In-depth research on Tesamorelin, BPC-157, TB-500, GHK-Cu, KPV, NAD+, Ipamorelin, MOTS-c, and other injectable compounds. All injectable peptides require a consultation before purchase.
IGF-1 LR3 is a modified version of insulin-like growth factor with a significantly extended half-life. Explore its mechanisms for muscle growth, recovery, and cellular health.
Ipamorelin selectively stimulates growth hormone release without affecting cortisol, prolactin, or appetite. Learn why it's considered the cleanest GH secretagogue available.
MOTS-c is encoded in mitochondrial DNA and activates AMPK — the same metabolic sensor triggered by exercise. Research shows effects on insulin sensitivity, fat metabolism, and aging.
PT-141 (bremelanotide) is an FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder. Learn about its unique central nervous system mechanism.
Cagrilintide is a long-acting amylin analog being studied for weight management. Learn how it differs from GLP-1 drugs, its mechanisms, and what clinical trials show.
Tesamorelin is the only FDA-approved GHRH analog for reducing visceral fat. Explore the clinical research, mechanisms, and what makes this peptide unique.
GHK-Cu is a naturally occurring copper peptide that declines with age. Research shows it modulates over 30% of human genes, shifting expression toward a younger pattern.
KPV is a powerful anti-inflammatory tripeptide that inhibits NF-κB signaling. Research shows it reduces intestinal inflammation and modulates immune responses without immunosuppression.
GLP-2 is a naturally occurring peptide that stimulates intestinal growth and repair. Learn about its mechanisms, clinical applications, and why it's gaining attention for gut health.
GLP-3 is an emerging area of peptide research building on the success of GLP-1 and GLP-2. Here's what the early science suggests about this next-generation peptide.